Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Yokoi, Fumiaki ^a   Dang, Mai Tu ^b   Li, Jianyong ^c   Standaert, David G ^d   Li, Yuqing ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^d The University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; MONOAMINE; CELL SURFACE RECEPTOR; CHAPERONE; DYT1 PROTEIN, MOUSE; STROMAL CELL DERIVED RECEPTOR 2, MOUSE; STROMAL CELL-DERIVED RECEPTOR 2, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY POSTURE; BRAIN CELL; BRAIN REGION; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; CORPUS STRIATUM; DNA ISOLATION; DOPAMINE METABOLISM; DYSTONIA; EXON; GENE MUTATION; HOMOZYGOSITY; KNOCKOUT MOUSE; LIGAND BINDING; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOUSE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PROTEIN FUNCTION; RECEPTOR BINDING; ROTAROD TEST; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL BEHAVIOR; BRAIN; CELL NUCLEUS; CROSS BREEDING; GENE DELETION; GENETICS; HOMOZYGOTE; METABOLISM; MOTOR PERFORMANCE; MOUSE MUTANT; MUTATION;

MUS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CELL NUCLEUS; CROSSES, GENETIC; GENE DELETION; HOMOZYGOTE; MALE; MICE; MICE, KNOCKOUT; MOLECULAR CHAPERONES; MOTOR SKILLS; MUTATION; PHENOTYPE; RECEPTORS, CELL SURFACE;

EID: 80052634773     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024539     Document Type: Article

References (43)

1. Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, et al. (2008) The pathophysiological basis of dystonias. Nat Rev Neurosci 9: 222-234.
2. Muller U, (2009) The monogenic primary dystonias. Brain 132: 2005-2025.
3. Ozelius LJ, Hewett JW, Page CE, Bressman SB, Kramer PL, et al. (1997) The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 17: 40-48.
4. Torres GE, Sweeney AL, Beaulieu JM, Shashidharan P, Caron MG, (2004) Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A 101: 15650-15655.
5. Hewett JW, Tannous B, Niland BP, Nery FC, Zeng J, et al. (2007) Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc Natl Acad Sci U S A 104: 7271-7276.
6. Kustedjo K, Deechongkit S, Kelly JW, Cravatt BF, (2003) Recombinant expression, purification, and comparative characterization of torsinA and its torsion dystonia-associated variant Delta E-torsinA. Biochemistry 42: 15333-15341.
7. Konakova M, Pulst SM, (2005) Dystonia-associated forms of torsinA are deficient in ATPase activity. J Mol Neurosci 25: 105-117.
8. Burdette AJ, Churchill PF, Caldwell GA, Caldwell KA, (2010) The early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro. Cell Stress Chaperones 15: 605-617.
9. Leung JC, Klein C, Friedman J, Vieregge P, Jacobs H, et al. (2001) Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics 3: 133-143.
10. Zirn B, Grundmann K, Huppke P, Puthenparampil J, Wolburg H, et al. (2008) Novel TOR1A mutation p.Arg288Gln in early-onset dystonia (DYT1). J Neurol Neurosurg Psychiatry 79: 1327-1330.
11. Ritz KGM, Foncke EM, van Ruissen F, van der Linden C, Vergouwen MD, Bloem BR, Vandenberghe W, Crols R, Speelman JD, Baas F, Tijssen MA, (2009) Myoclonus-dystonia: clinical and genetic evaluatio. [J Neurol Neurosurg Psychiatry. 2009]- PubMed result. J Neurol Neurosurg Psychiatry 80: 653-658.
12. Dang MT, Yokoi F, McNaught KS, Jengelley TA, Jackson T, et al. (2005) Generation and Characterization of Dyt1 deltaGAG Knock-in Mouse as a Model for Early-Onset Dystonia. Exp Neurol 196: 452-463.
13. Cao S, Hewett JW, Yokoi F, Lu J, Buckley AC, et al. (2010) Chemical enhancement of torsinA function in cell and animal models of torsion dystonia. Dis Model Mech 3: 386-396.
14. Yokoi F, Yang G, Li J, Deandrade MP, Zhou T, et al. (2010) Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce. J Biochem 148: 459-466.
15. Dang MT, Yokoi F, Pence MA, Li Y, (2006) Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci Res 56: 470-474.
16. Yokoi F, Dang MT, Mitsui S, Li J, Li Y, (2008) Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout mice. J Biochem 143: 39-47.
17. Furukawa Y, Hornykiewicz O, Fahn S, Kish SJ, (2000) Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology 54: 1193-1195.
18. Augood SJ, Hollingsworth Z, Albers DS, Yang L, Leung JC, et al. (2002) Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology 59: 445-448.
19. Asanuma K, Ma Y, Okulski J, Dhawan V, Chaly T, et al. (2005) Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 64: 347-349.
20. Napolitano F, Pasqualetti M, Usiello A, Santini E, Pacini G, et al. (2010) Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Neurobiol Dis 38: 434-445.
21. Naismith TV, Heuser JE, Breakefield XO, Hanson PI, (2004) TorsinA in the nuclear envelope. Proc Natl Acad Sci U S A 101: 7612-7617.
22. Gonzalez-Alegre P, Paulson HL, (2004) Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia. J Neurosci 24: 2593-2601.
23. Goodchild RE, Dauer WT, (2004) Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc Natl Acad Sci U S A 101: 847-852.
24. Goodchild RE, Kim CE, Dauer WT, (2005) Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 48: 923-932.
25. Grundmann K, Reischmann B, Vanhoutte G, Hubener J, Teismann P, et al. (2007) Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol Dis 27: 190-206.
26. Kim CE, Perez A, Perkins G, Ellisman MH, Dauer WT, (2010) A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. Proc Natl Acad Sci U S A 107: 9861-9866.
27. Sauer B, Henderson N, (1988) Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci U S A 85: 5166-5170.
28. Schwenk F, Baron U, Rajewsky K, (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23: 5080-5081.
29. Dang MT, Yokoi F, Yin HH, Lovinger DM, Wang Y, et al. (2006) Disrupted motor learning and long-term synaptic plasticity in mice lacking NMDAR1 in the striatum. Proc Natl Acad Sci U S A 103: 15254-15259.
30. McBride WJ, Chernet E, Dyr W, Lumeng L, Li TK, (1993) Densities of dopamine D2 receptors are reduced in CNS regions of alcohol-preferring P rats. Alcohol 10: 387-390.
31. Wang Y, Xu R, Sasaoka T, Tonegawa S, Kung MP, et al. (2000) Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J Neurosci 20: 8305-8314.
32. Pisani A, Martella G, Tscherter A, Bonsi P, Sharma N, et al. (2006) Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol Dis 24: 318-325.
33. Wang Z, Kai L, Day M, Ronesi J, Yin HH, et al. (2006) Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50: 443-452.
34. Shen W, Flajolet M, Greengard P, Surmeier DJ, (2008) Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321: 848-851.
35. Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Lagrange C, et al. (2007) Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol 6: 223-229.
36. Campos VE, Du M, Li Y, (2004) Increased seizure susceptibility and cortical malformation in beta-catenin mutant mice. Biochem Biophys Res Commun 320: 606-614.
37. Zhang L, Yokoi F, Jin YH, Deandrade MP, Hashimoto K, et al. (2011) Altered Dendritic Morphology of Purkinje cells in Dyt1 DeltaGAG Knock-In and Purkinje Cell-Specific Dyt1 Conditional Knockout Mice. PLoS One 6: e18357.
38. Yokoi F, Dang MT, Miller CA, Marshall AG, Campbell SL, et al. (2009) Increased c-fos expression in the central nucleus of the amygdala and enhancement of cued fear memory in Dyt1 DeltaGAG knock-in mice. Neurosci Res 65: 228-235.
39. Fernagut P, Diguet E, Stefanova N, Biran M, Wenning G, et al. (2002) Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. Neuroscience 114: 1005.
40. Cao BJ, Li Y, (2002) Reduced anxiety- and depression-like behaviors in Emx1 homozygous mutant mice. Brain Res 937: 32-40.
41. Yokoi F, Dang MT, Li J, Li Y, (2006) Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice. J Biochem 140: 141-146.
42. DeAndrade MP, Yokoi F, van Groen T, Lingrel JB, Li Y, (2011) Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism. Behav Brain Res 216: 659-665.
43. Terai M, Hidaka K, Nakamura Y, (1989) Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum. Eur J Pharmacol 173: 177-182.